Coya Therapeutics
(NASDAQ) COYA
Coya Therapeutics Financials at a Glance
Market Cap
$103.68M
Revenue (TTM)
$7.94M
Net Income (TTM)
-$21.13M
EPS (TTM)
-$1.08
P/E Ratio
-4.09
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$4.43
Volume
234,165.113
Open
$5.06
Price
$4.43
Volume
234,165.113
Open
$5.06
Previous Close
$4.42
Daily Range
$4.41 - $5.10
52-Week Range
$3.71 - $7.75
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$4.43
Volume
234,165.113
Open
$5.06
Previous Close
$4.42
Daily Range
$4.41 - $5.10
52-Week Range
$3.71 - $7.75
Estimated Earnings Date
Aug 11, 2026
COYA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Coya Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Arun Swaminathan, PhD
Website
www.coyatherapeutics.comHeadquarters
Houston, TX 77057, US
COYA Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-51%
Return on Capital
-44%
Return on Assets
-40%
Earnings Yield
-24.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$103.68M
Shares Outstanding
23.46M
Volume
234.17K
Avg. Volume
157.80K
Financials (TTM)
Gross Profit
$7.92M
Operating Income
-$20.27M
EBITDA
-$20.24M
Operating Cash Flow
-$10.74M
Capital Expenditure
$0.00
Free Cash Flow
-$10.74M
Cash & ST Invst.
$46.82M
Total Debt
$0.00
Coya Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$251.15K
-2.6%
Gross Profit
$248.34K
+105.0%
Gross Margin
98.88%
N/A
Market Cap
$103.68M
N/A
Market Cap/Employee
$12.96M
N/A
Employees
8
N/A
Net Income
-$7.21M
+1.4%
EBITDA
-$7.63M
+0.6%
Quarterly Fundamentals
Net Cash
$50.72M
+42.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-39.66%
N/A
Return on Invested Capital
-44.23%
N/A
Free Cash Flow
-$6.21M
-119.5%
Operating Cash Flow
-$6.21M
-119.5%